Lido Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,300
Closed -$18.7K 1473
2025
Q1
$18.7K Buy
+15,300
New +$18.7K ﹤0.01% 1353